Current Liabilities
Accrued Manufacturing Costs
Thermo Fisher Scientific Accrued Manufacturing Costs decreased by 21.6% to $1.57B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 10.3%, from $1.42B to $1.57B. Over 5 years (FY 2020 to FY 2025), Accrued Manufacturing Costs shows relatively stable performance with a 0.8% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
First reportedQ4 2014
Last reportedQ1 2026May 1, 2026
Metric ID:
accrued_manufacturing_costsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.49B | $1.82B | $2.43B | $1.63B | $1.72B | $1.86B | $2.10B | $1.31B | $1.31B | $1.46B | $1.60B | $1.31B | $1.50B | $1.82B | $1.99B | $1.42B | $1.52B | $1.88B | $2.00B | $1.57B |
| QoQ Change | — | +21.7% | +33.6% | -32.7% | +5.4% | +8.2% | +12.4% | -37.6% | +0.2% | +11.5% | +9.3% | -17.7% | +13.8% | +21.9% | +9.1% | -28.6% | +7.0% | +24.1% | +5.9% | -21.6% |
| YoY Change | — | — | — | — | +15.4% | +2.6% | -13.7% | -20.0% | -23.9% | -21.7% | -23.8% | +0.5% | +14.1% | +24.9% | +24.6% | +8.0% | +1.5% | +3.3% | +0.4% | +10.3% |
Range$1.31B – $2.43B
CAGR+1.0%
Avg YoY Growth+0.2%
Median YoY Growth+2.1%
Accrued Manufacturing Costs at Other Companies
Frequently Asked Questions
- What is Thermo Fisher Scientific's accrued manufacturing costs?
- Thermo Fisher Scientific (TMO) reported accrued manufacturing costs of $1.57B in Q1 2026.
- How has Thermo Fisher Scientific's accrued manufacturing costs changed year-over-year?
- Thermo Fisher Scientific's accrued manufacturing costs increased by 10.3% year-over-year, from $1.42B to $1.57B.
- What is the long-term trend for Thermo Fisher Scientific's accrued manufacturing costs?
- Over 5 years (2020 to 2025), Thermo Fisher Scientific's accrued manufacturing costs has grown at a 0.8% compound annual growth rate (CAGR), from $1.92B to $2.00B.